Background Greater trochanteric pain syndrome (GTPS) is common, resulting in significant pain and disability. There is no condition specific outcome score to evaluate the degree of severity of GTPS in or effectiveness of treatment for, patients with this condition.
INTRODUCTION
Greater trochanteric pain syndrome (GTPS) is a common, chronic, disabling condition characterised by intermittent or continuous pain at, or around, the greater trochanter of the femur.[1 2 3] The condition can be debilitating enough to reduce activity and capacity for employment. [4] GTPS has a reported incidence of 1.8 patients per 1000 per year in primary care. [5] Prevalence rates of 23.5% in women at risk of knee osteoarthritis [6] and 54% in recipients of renal transplants [7] have been reported. These statistics likely underestimate the prevalence of GTPS as misdiagnosis of GTPS is common. [8] [9] [10] [11] Risk factors for developing GTPS are poorly understood however female gender, older age, [1 6] greater adiposity, [6] back pain [4 6 ] and a higher femoral neck angle [12] have been associated with the condition. Older women are over represented in GTPS by a ratio of approximately 4:1, [5 6 ] with the reported age of diagnosis of between 45 and 63 years. [1 5 6] Despite the reported prevalence and disability, a condition specific patient reported outcome (PRO) tool has not been developed for this condition. Surrogate measures using tools designed for hip osteoarthritis or low back pain have been used. [1 4 13] Evaluation of the level of severity, and of the effectiveness of treatment across studies would be enhanced by the use of a PRO. [14 15] The VISA questionnaires have a consistent structure has been shown to be valid for the assessment of lower limb tendinopathies. The VISA-P, VISA-A and VISA-H have been widely adopted to quantify the disability associated with patellar, Achilles and hamstring tendinopathy respectively. [16] [17] [18] Additionally, their purpose is to monitor and evaluate treatment strategies for these conditions. [19] As GTPS is a tendinopathy involving the gluteus medius and minimus tendons, [20] [21] [22] [23] [24] the VISA questionnaire structure may be a valid to adopt for this population. The objective of this study was to develop a valid PRO questionnaire, based on the VISA questionnaire structure, for people with GTPS. The development of the VISA-G followed the Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) guidelines for the development and testing of health measurement instruments provide a methodology for the development health measurement tools. [25] 
METHODS
The development of this instrument used qualitative and quantitative methods using three steps:
(1) item generation and format refinement, (2) item reduction, and (3) evaluation of the psychometric properties of the final version. [26] Existing VISA questionnaires were used to guide the format of the VISA-G. [16] [17] [18] 
Participants
Participants were recruited via social and professional networks. Participants were screened for exclusion criteria and then provided with a comprehensive participant information sheet before providing written consent. Ethical approval for this study was provided by ACT health human research ethics committee, Australian National University human research ethics committee, Calvary health care ACT human research ethics committee, Deakin University human research ethics committee, and the Monash University human research ethics committee.
Inclusion criteria

GTPS participants:
In the item generation stage of this research GTPS participants were identified by clinician as having trochanteric bursitis and / or gluteal tendinopathy as the primary diagnosis. In subsequent stages GTPS was defined as a history of lateral hip pain,[2 3 6 20 24 27-30] pain on palpation of the greater trochanter,[1 2 3 20 28 29 31] and one or both of lateral hip pain with lying on the ipsilateral side, [1 29 31 ] or during weight bearing activities or sitting. [2 11 31] Asymptomatic participants Participants were included in the asymptomatic group if they were healthy with no current or history of back or hip pain requiring them to seek treatment for the condition.
Exclusion criteria
Participants were excluded if they had any signs or symptoms of hip OA based on Altman criteria [33] , systemic inflammatory disease e.g. rheumatoid arthritis; lumbar spine nerve root signs; a history of lumbar spine or ipsilateral hip joint surgery; osteogenic disease e.g. Paget's disease; or a corticosteroid injection to the ipsilateral lateral hip region in the preceding three months.
Participants with co-morbidities that restricted their activity level more than their hip pain did -thus invalidating question eight (Q8), were also excluded.
Health professional inclusion
Physiotherapists were invited to attend two focus groups. Fifteen to 20 physiotherapists were present at each meeting with experience ranging from new graduate to extensive (post graduate musculoskeletal training and more 20 years of experience). No physiotherapist was excluded.
One sports physician, two orthopaedic surgeons and a physician with a post graduate diploma in ultrasound imaging, all with an interest in the condition were involved in the item generation on a one-to-one discussion basis.
Process
Step 1 Item generation Item generation was undertaken using a number of methods: A literature review identified items noted in the literature; focus groups of physiotherapists discussed the literature review findings in addition to their personal observations of presentation and dysfunction of clients with GTPS; and semi-structured interviews of people with GTPS (N=42). The information from the literature review, the focus groups and the in depth interviews provided triangulation of data. [32] These data were condensed into a draft questionnaire. Trial questionnaires were sent to interview participants for testing of question accuracy, clarity and questionnaire design. [33] This was done in an iterative fashion -until no new domains were elicited. The subsequent iteration was trialled on 73 naive GTPS participants. These data informed the item reduction.
Step 2 Item reduction Item reduction was undertaken by two experienced research physiotherapists (AF & JC). The results from the questionnaire were evaluated for domain generation using principal component analysis and scree plots, and for redundancy using Spearman Rho correlation. In this early version, ceiling and floor effects were tested via descriptive statistics. This process resulted in a reduction from 21 to seven questions. In line with the VISA questionnaire model two questions regarding level of activity (Q7 & Q8) were added to account for variation in tendon pain due to variation in tendon loading. [17 18] Step 3 Item scaling As with existing VISA scores, the first six questions were scored between 0 and 10, while the categorisation questions (7 and 8) were scored out of 10 and 30 respectively.
Step 4 Evaluation of psychometric properties
The final version of the VISA-G had a visual analogue score for pain (0 = worst pain, 10 = no pain), four questions related to pain (Questions 2,3, 4 and 6), one question related to difficulty with moving after sitting (Question 5) and two activity related questions (Questions 7 and 8). This version of the VISA-G (Attachment A) was tested on 52 naïve participants with GTPS; 49 women (mean age (SD)) 58.9 (13.64), and 3 men (53.0, SD 15.13). In addition 31 asymptomatic participants were tested: 24 women (57.4 (5.59) and 7 men (58. 4 (5.22) . Three asymptomatic participants did not specify their gender or age on the questionnaire.
Internal consistency: Internal consistency is the degree to which the items in questionnaire are interrelated. [25] A principal component factor analysis was performed on the individual items to determine their structural validity. A Cronbach's alpha and 95% confidence intervals was calculated for each item and a score above 0.70 was taken as a sufficient level of homogeneity among the items. [34] Test retest reliability: An intraclass correlation coefficient (ICC) was used to compare VISA-G scores of 26 GTPS participants who completed the PROs one week apart. Floor and Ceiling effects: Floor and ceiling effects were examined by evaluating the distribution of total scores and determining if more than 15% of the participants achieved either the lowest or the highest score.
Data analysis
Statistical analysis for data reduction was undertaken using Stata IC 10.1 (Statacorp, USA). Statistical analysis for stability and groups differences was undertaken using SPSS Statistics (version 19, IBM SPSS Inc. Chicago, IL, USA).
Eighty three complete questionnaires were used in the analysis, no imputation was used for missing items.
Item reduction:
Multivariate techniques including factor analysis, bi-plots and Spearman rho correlation coefficients were employed. Using Factor Analysis results, two researchers reviewed the eigenvalues and loading factor for each question in VISA-Gv1. Biplots were used to examine the variance of each question, a higher variance was assumed to be associated with lower specificity of the domain. Spearman rho correlation co-efficient in combination with the factor analysis was used to identify items that appeared to measure the same construct, thus identifying redundancy and allowing question deletion. For example the level of discomfort associated with pushing a shopping trolley will depend upon how full the trolley is, likewise, the discomfort associated with getting in or out of a car will depend on which leg is affected and whether you are the driver or the passenger.
We retained the five questions that covered 95% of the variance in the questionnaire. Thus we reduced the questionnaire from 22 questions to six (the five plus the pain VAS). To account for variation in tendon pain due to variation in tendon loading, [17 18 ] questions regarding level of activity (similar to VISA-A and VISA-P) was added to the final version (questions 7 and 8).
Results
Participants with GTPS had scores associated with higher levels of pain and dysfunction than the asymptomatic participants (Table 1) . High scores for VISA-G and HHS indicate less disability. Lower scores for the ODI indicate less disability. Question eight had a mean (SD) of 14.64 (13.28).
Psychometric Testing
Test-retest reliability:
Validity
Face validity: The extensive item generation, logical item reduction, and the rigorous trialling over time with naive populations of symptomatic and asymptomatic people confers face validity.
Construct validity: Spearman correlation coefficient analysis illustrates the correlations between the VISA-G, HHS and ODI (Table 2 ). In participants with GTPS, the VISA-G did not correlate with either the HHS or the ODI, while in the asymptomatic group the VISA-G did correlate with the HHS, but not the ODI. VISA-G = VISA score for GTPS; HHS = Harris Hip Score; ODI = Oswestry Disability Index
Content Validity: The development process for the VISA-G, including people with GTPS and two forms of clinicians, suggests that the questionnaire has content validity.
Floor and ceiling effects:
No floor or ceiling effects were identified in the GTPS group with less than 15% of participants in the GTPS groups scoring the minimum or maximum values. Not surprisingly, 94% of the asymptomatic group scored the maximum value.
Discussion
The objective of this study was to develop a reliable and valid PRO questionnaire to assess the severity of, and efficacy of treatment for, GTPS. We have demonstrated that the VISA-G has good reliability -both internally and on a test-retest basis. The VISA-G has been shown to have content and construct validity. Concurrent criterion validity has been demonstrated, although not predictive criterion validity, thus meeting the majority of the COSMIN standards. Further research is needed to complete the process of demonstrating responsiveness and minimal clinical significance.
The validity of the VISA-G was assessed with the rigorous and recursive nature of the initial item generation and thorough item identification. While some of the questions overlap with the Harris Hip Score, [37] the scores from HHS and the VISA-G did not correlate, suggesting that the two scores are measuring different constructs. The high internal consistency further supports this, as does the result that people with GTPS scored higher on the VISA-G score than the control group.
The VISA-G has internal consistency for the questions that evaluated the GTPS construct (Q 1 -6).
The remaining questions modulate the effect of activity on the total score, consistent with the standard VISA format. [17 18 38] The HHS, ODI and the non-arthritic hip score [39] do not have such influential questions.
The activity level question (Q 8) in existing VISA scores focus on sport and training activities. Our item generation did not identify sport as a major activity of people with GTPS. Rather, walking and shopping were more common activities impacted on by GTPS. We amended this question in the VISA-G to weight bearing activities. This move away from sport related activities reflects the different age group that is represented in population with GTPS, as opposed to the younger and more active population with patellar tendinopathy particularly, [18] Achilles tendinopathy [17] and hamstring tendinopathy. [38] The VISA-G is a measure of severity of GTPS and is not diagnostic, diagnosis should be clinical with a history and examination, including using the FABER test. [40] Patients with GTPS are likely to have comorbidities such as pain generated from the back and hip joint and the VISA-G score will likely be influenced by these. Interestingly, GTPS participants with non-specific low back pain (without referral) were included in this study, yet the correlation with the ODI in this population was not significant. This suggests that the VISA-G is responsive to GTPS independently of back pain symptoms. This is noteworthy when considering the study that treated GTPS in people diagnosed with back pain, and found an improvement in the ODI score. [13] The VISA-G is modelled on existing VISA tendon outcome tools. [17 18 38] The VISA-G follows the standard VISA format, importantly including measures of activity level (Questions 7 and 8). It is expected that in line with other VISA tools Q1 -6 are likely to be very responsive to change, but Q7 and 8 likely to be slower -thus re-testing should only be done on a monthly or bi-monthly period.
Limitations
A limitation of this study was that the GTPS participants represent people seeking conservative physiotherapy treatment. GTPS can be treated with corticosteroid injections and tendon reconstructions, [41 42 ] thus the VISA-G has not been tested a cross the full spectrum of a population with GTPS. In addition, testing of responsiveness and establishing minimum clinical significance was not possible with a cross-sectional study design.
Conclusion
This study found that the VISA-G is reliable and valid. It will be a useful tool for evaluating the severity of disability in, and the effectiveness of treatment for people with GTPS.
WHAT ARE THE NEW FINDINGS 1. A Valid and reliable tool for measuring the severity of GTPS. 2. VISA-G provides a tool for measuring the effectiveness of treatment for GTPS in both clinical and research settings.
HOW MIGHT THIS IMPACT OF CLINICAL PRACTICE IN THE NEAR FUTURE
• The VISA-G provides clinicians with an object method of measuring changes in people with GTPS, thus informing ongoing treatment.
• The VISA-G provides researchers with an object method of measuring changes in people with GTPS, thus making the results of research more convincing.
ACKNOWLEDGEMENTS
The VISA -G was developed at the Trauma and Orthopaedic Research Unit at the Canberra Hospital, with reliability and validity testing undertaken at Monash University.
Physiotherapist from the Canberra region and Doctors Rob Reid, Alexander Burn and Wes Cormick helped with the item generation.
Dr T Neeman from the Statistical Consulting Unit, the Australian National University, assisted with the item reduction.
The study was funded through Australian National University research funding and Monash University grants…..
